Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed

Intensive Care Medicine

Volumn 28, Issue 7, 2002, Pages 925-929

  Hennersdorf, Marcus G ^a   Perings, Stefan M ^a   Zühlke, Christian ^a   Heidland, Ulrich E ^a   Perings, Christian ^a   Heintzen, Matthias P ^a   Strauer, Bodo E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Amiodarone; Atrial fibrillation; Conversion; Ibutilide

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; IBUTILIDE; SULFONAMIDE; MAGNESIUM; POTASSIUM;

AGED; ARTICLE; CARDIOVERSION; ELECTROCARDIOGRAPHY; GERMANY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; ADULT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DISEASE DURATION; DOSE RESPONSE; EVALUATION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART PROARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; MALE; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; QT INTERVAL; SINUS RHYTHM; SYMPTOM; TORSADE DES POINTES; TREATMENT FAILURE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; GERMANY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MIDDLE AGED; SULFONAMIDES; TREATMENT OUTCOME; HUMAN; MIDDLE AGE;

EID: 0036020312     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1317-3     Document Type: Article

References (24)

1. Management of atrial fibrillation: Therapeutical options and clinical decisions
2. Tachyarrhythmias in a surgical intensive care unit: A case-controlled epidemiologic study
3. Incidence and type of cardiac arrhythmias in critically ill patients: A single center experience in a medical-cardiological ICU
4. Pathophysiology, epidemiology and complications of atrial fibrillation
5. Drug choices in the treatment of atrial fibrillation
6. Intravenous amiodarone for acute heart rate control in the critically ill patients with atrial tachyarrhythmias
7. Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone
8. Ibutilide
9. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
10. Superiority of ibutilide (a new class III agent) over dl-sotalol in converting atrial flutter and atrial fibrillation
11. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
12. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy
13. Ibutilide
14. Ibutilide and the treatment of atrial arrhythmias
15. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
16. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing
17. Termination of recent-onset atrial fibrillation/flutter in the emergency department: A sequential approach with intravenous ibutilide and external electrical cardioversion
18. Intravenous amiodarone for therapy of atrial fibrillation or flutter in critically ill patients with severely depressed left ventricular function
19. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study
20. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter
21. Mechanisms and management of proarrhythmia
22. Characterization of magnesium sulfate as an antiarrhythmic agent
23. Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia
24. Acute treatment of atrial fibrillation: Spontaneous conversion rates and cost of care